Wickliffe Pharmaceutical, Inc.
Untitled letter response sent about July 23, 2024 (estimated*) · Lexington, Kentucky
- Pages
- 10
- FEI number
- 3002992930
* Estimated date, added by FDA Intel's parsing systems. The reply itself is undated. It answers FDA's untitled letter of June 10, 2024, which asked for a reply within 30 working days (about July 23, 2024), and it commits to finishing one action by August 15, 2024. The same firm's replies to its other untitled letters were sent four to six weeks after each letter. We use the reply deadline, July 23, 2024.
In short: This is Wickliffe Pharmaceutical, Inc.'s written response to FDA, dated July 23, 2024, for its site in Lexington, Kentucky (FEI 3002992930). It sets out the corrective actions the firm committed to.
Inside this response
This inspection in context
Questions about this response
When was Wickliffe Pharmaceutical, Inc. inspected by FDA?
This Untitled letter response is dated July 23, 2024.
How do I get the full Untitled letter response for Wickliffe Pharmaceutical, Inc.?
Download the original PDF from FDA Intel for $199, with no subscription. You also get an invoice PDF with the order.